Evidence map›Paper›PMID 32656732›Full record

ReviewLasers in medical science2020

ILIB (intravascular laser irradiation of blood) as an adjuvant therapy in the treatment of patients with chronic systemic diseases-an integrative literature review.

Ruan Felipe Ferreira Tomé, Diego Filipe Bezerra Silva, Carlus Alberto Oliveira Dos Santos, Gabriella de Vasconcelos Neves, Ana Karina Almeida Rolim, Daliana Queiroga de Castro Gomes

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lasers in medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ruan Felipe Ferreira ToméFaculdades Integradas de Patos, R. Horácio Nóbrega, S/N, Belo Horizonte, 58704-000, Brazil.
Diego Filipe Bezerra SilvaPost Graduate Program in Dentistry, State University of Paraíba, R. Baraúnas, 351 - Bairro Universitário, Campina Grande, PB, 58429-500, Brazil. diegofilipeb@gmail.com.ORCID https://orcid.org/0000-0002-6721-0745
Carlus Alberto Oliveira Dos SantosPost Graduate Program in Dentistry, State University of Paraíba, R. Baraúnas, 351 - Bairro Universitário, Campina Grande, PB, 58429-500, Brazil.ORCID https://orcid.org/0000-0002-5988-1186
Gabriella de Vasconcelos NevesPost Graduate Program in Dentistry, State University of Paraíba, R. Baraúnas, 351 - Bairro Universitário, Campina Grande, PB, 58429-500, Brazil.ORCID https://orcid.org/0000-0002-9682-5386
Ana Karina Almeida RolimPost Graduate Program in Dentistry, State University of Paraíba, R. Baraúnas, 351 - Bairro Universitário, Campina Grande, PB, 58429-500, Brazil.ORCID https://orcid.org/0000-0001-6910-2898
Daliana Queiroga de Castro GomesPost Graduate Program in Dentistry, State University of Paraíba, R. Baraúnas, 351 - Bairro Universitário, Campina Grande, PB, 58429-500, Brazil.ORCID https://orcid.org/0000-0002-3154-7039
Universidade Estadual da Paraíba · BRFaculdades Integradas de Taquara · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To perform an integrative review of the literature on the effectiveness of intravascular laser irradiation of blood (ILIB) as an adjunct therapy in the treatment of chronic systemic diseases. This is an integrative literature review that included non-randomized and randomized controlled clinical trials that specifically evaluated the therapeutic effect of ILIB on chronic systemic diseases, without restriction of time, and written in English. The Medical Publications (PubMed)/MEDLINE database was used. MeSH (Medical Subject Headings) was used to select search descriptors with the Boolean operators "AND/OR." After applying the inclusion and exclusion criteria, 13 articles were selected. Coronary diseases were the most prevalent, followed by type 2 diabetes mellitus, with the coronary artery being the most widely used access route for ILIB application. Despite the varied parameters and protocols for using this kind of therapy, all studies have shown satisfactory results in the patients' clinical condition. ILIB proved to be effective in all organic systems, showing some positive result. However, studies on the effect of this therapy on various diseases are still scarce in the literature, and there is a need for more well-designed clinical trials to better understand the role of ILIB in various systemic diseases.

Indexed as

Low-Level Light TherapyAdultAgedChildChronic DiseaseDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedBloodDiseaseHumansLow-level light therapy

Identifiers

PMID32656732
OpenAlexW3041325928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.